Market Mover: Apellis (APLS) Climbs at Midday August 5

Equities Staff  |

Apellis Pharmaceuticals Inc (NASDAQ: APLS) shares have risen 7.62%, or $4.41 per share, as on 11:46:44 est today. Since opening the day at $60.90, 169,276 shares of Apellis have traded hands and the stock has traded between $62.38 and $59.44.  

So far this year the company has a YTD change of 29.72%.

Apellis is set to release earnings on 2022-08-08.

For technical charts, analysis, and more on Apellis visit the company profile.

About Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, the company aims to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology.

To get more information on Apellis Pharmaceuticals Inc and to follow the company's latest updates, you can visit the company's profile page here: Apellis Pharmaceuticals Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Strong Dollar Is a Problem for Stocks
3 Ways Finance Teams Can Navigate Inflation Through Automation



Market Movers

Sponsored Financial Content